UBS Group’s XORTX Therapeutics XRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8K | Buy |
+20,790
| New | +$18.8K | ﹤0.01% | 7176 |
|
|
2025
Q1 | – | Sell |
-17,428
| Closed | -$19.7K | – | 9289 |
|
|
2024
Q4 | $19.7K | Sell |
17,428
-1,352
| -7% | -$1.53K | ﹤0.01% | 6648 |
|
|
2024
Q3 | $30.8K | Buy |
+18,780
| New | +$30.8K | ﹤0.01% | 5914 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$53 | – | 9102 |
|
|
2022
Q4 | $53 | Buy |
+1
| New | +$53 | ﹤0.01% | 9270 |
|
|
2022
Q3 | – | Sell |
-70
| Closed | -$8K | – | 9757 |
|
|
2022
Q2 | $8K | Buy |
70
+24
| +52% | +$2.74K | ﹤0.01% | 7322 |
|
|
2022
Q1 | $7K | Buy |
46
+32
| +229% | +$4.87K | ﹤0.01% | 7795 |
|
|
2021
Q4 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 8712 |
|